COZZI, ANDREA
COZZI, ANDREA
Medicina Sperimentale e Clinica
1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia
1999 Pellegrini-Giampietro D.E.; Cozzi A.; Leonardi P.; Peruginelli F.; Meli E.; Pellicciari R.; Moroni F.
Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo.
2002 Meli E.; Picca R.; Attucci S.; Cozzi A.; Peruginelli F.; Moroni F.; Pellegrini-Giampietro D.E.
Acute phencyclidine administration reduces extracellular glutamate levels and the expression of synaptophysin and SNAP-25 in rat frontal cortex
2009 Fattorini G.; Bragina L.; Candiracci C.; Melone M.; Cozzi A.; Pellegrini-Giampietro D.E.; Conti F
Alteration of the subcellular and tissue distribution of ELAV-type proteins during cerebral ischemia in the rat
2000 Pacini A.; Quattrone A.; Sassoli C.; Cesati V.; Peruginelli F.; Cozzi A.; Moroni F.; Pacini P
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors
2015 Di Cesare Mannelli, Lorenzo; Micheli, Laura; Carta, Fabrizio; Cozzi, Andrea; Ghelardini, Carla; Supuran, Claudiu T
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study
2018 Stasi, Cristina; Silvestri, Caterina; Berni, Roberto; Brunetto, Maurizia Rossana; Zignego, Anna Linda; Orsini, Cristina; Milani, Stefano; Ricciardi, Liana; Luca, Andrea De; Blanc, Pierluigi; Nencioni, Cesira; Aquilini, Donatella; Bartoloni, Alessandro; Bresci, Giampaolo; Marchi, Santino; Filipponi, Franco; Colombatto, Piero; Forte, Paolo; Galli, Andrea; Luchi, Sauro; Chigiotti, Silvia; Nerli, Alessandro; Corti, Giampaolo; Sacco, Rodolfo; Carrai, Paola; Ricchiuti, Angelo; Giusti, Massimo; Almi, Paolo; Cozzi, Andrea; Carloppi, Silvia; Laffi, Giacomo; Voller, Fabio; Cipriani, Francesco
Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors
2002 L. Giovannelli; A. Cozzi; I. Guarnieri; P. Dolara; F. Moroni
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia.
2008 Landucci E.; Scartabelli T.; Cozzi A.; Boscia F.; Mannaioni G.; Annunziato L.; Moroni F.; Pellegrini-Giampietro D.E.
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany
2019 Cristina Stasi; Caterina Silvestri; Roberto Berni; Maurizia Rossana Brunetto; Anna Linda Zignego; Cristina Orsini; Stefano Milani; Liana Ricciardi; Andrea De Luca; Pierluigi Blanc; Cesira Nencioni; Donatella Aquilini; Alessandro Bartoloni; Giampaolo Bresci; Santino Marchi; Franco Filipponi; Piero Colombatto; Paolo Forte; Andrea Galli; Sauro Luchi; Silvia Chigiotti; Alessandro Nerli; Giampaolo Corti; Rodolfo Sacco; Paola Carrai; Angelo Ricchiuti; Massimo Giusti; Paolo Almi; Andrea Cozzi; Silvia Carloppi; Giacomo Laffi; Fabio Voller; Francesco Cipriani
GAT-1 regulates both tonic and phasic GABAA receptor-mediated inhibition in the cerebral cortex
2008 L. BRAGINA; I. MARCHIONNI; A. OMRANI; A. COZZI; D.E. PELLEGRINI-GIAMPIETRO; E. CHERUBINI; F. CONTI
GLT-1 expression and glutamate uptake in rat cerebral cortex are increased by phencyclidine
2008 G.Fattorini; M.Melone; L.Bragina; C.Candiracci; A.Cozzi; D.E.Pellegrini-Giampietro; M.Torres-Ramos; A.Pérez-Samartín; C.Matute; F.Conti
GPR35 is functionally expressed in astrocytes and mediates kynurenic acid-dependent reduction of excitatory synaptic activity at CA3-CA1 synapse.
2010 Masi A; Cavone L; Sili M; Cozzi A; Berlinguer Palmini R; Cosi C; Moroni F; Mannaioni G
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment
2007 A.L. Zignego; A. Cozzi; R. Carpenedo; C. Giannini; M. Rosselli; T. Biagioli; A. Aldinucci; G. Laffi; F. Moroni
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia
2008 Landucci E.; Scartabelli T.; Moneti G.; Boscia F.; Cozzi A.; Moroni F.; Mannaioni G.; Pellegrini-Giampietro D.E.
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia
2009 E.Landucci; F.Boscia; E.Gerace; T.Scartabelli; A.Cozzi; F.Moroni; G.Mannaioni; D.E.Pellegrini-Giampietro
Kynurenic acid actions in brain and periphey
2007 F. Moroni; S. Fossati; A. Chiarugi; A. Cozzi
Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.
2005 C. DI SERIO; A. COZZI; I. ANGELI; L. DORIA; I. MICUCCI; S. PELLERITO; P. MIRONE; G. MASOTTI; F. MORONI; F. TARANTINI
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery.
2012 F. Moroni;A. Cozzi;M. Sili;G. Mannaioni
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis.
2001 CHIARUGI A; COZZI A; BALLERINI C; MASSACESI L; F. MORONI
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus
2005 F. MORONI; A. COZZI; R. CARPENEDO; G. CIPRIANI; O. VENERONI; E. IZZO
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
1-Amino-1,5-dicarboxylic acid and (S)-(+)-2-(3'-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischemia | 1999 | Pellegrini-Giampietro D.E.; Cozzi A.; Leonardi P.; Peruginelli F.; Meli E.; Pellicciari R.; Moroni F. | |
Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to post-ischemic neuronal injury in vitro and in vivo. | 2002 | Meli E.; Picca R.; Attucci S.; Cozzi A.; Peruginelli F.; Moroni F.; Pellegrini-Giampietro D.E. | |
Acute phencyclidine administration reduces extracellular glutamate levels and the expression of synaptophysin and SNAP-25 in rat frontal cortex | 2009 | Fattorini G.; Bragina L.; Candiracci C.; Melone M.; Cozzi A.; Pellegrini-Giampietro D.E.; Conti F | |
Alteration of the subcellular and tissue distribution of ELAV-type proteins during cerebral ischemia in the rat | 2000 | Pacini A.; Quattrone A.; Sassoli C.; Cesati V.; Peruginelli F.; Cozzi A.; Moroni F.; Pacini P | |
Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors | 2015 | Di Cesare Mannelli, Lorenzo; Micheli, Laura; Carta, Fabrizio; Cozzi, Andrea; Ghelardini, Carla; Supuran, Claudiu T | |
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study | 2018 | Stasi, Cristina; Silvestri, Caterina; Berni, Roberto; Brunetto, Maurizia Rossana; Zignego, Anna Linda; Orsini, Cristina; Milani, Stefano; Ricciardi, Liana; Luca, Andrea De; Blanc, Pierluigi; Nencioni, Cesira; Aquilini, Donatella; Bartoloni, Alessandro; Bresci, Giampaolo; Marchi, Santino; Filipponi, Franco; Colombatto, Piero; Forte, Paolo; Galli, Andrea; Luchi, Sauro; Chigiotti, Silvia; Nerli, Alessandro; Corti, Giampaolo; Sacco, Rodolfo; Carrai, Paola; Ricchiuti, Angelo; Giusti, Massimo; Almi, Paolo; Cozzi, Andrea; Carloppi, Silvia; Laffi, Giacomo; Voller, Fabio; Cipriani, Francesco | |
Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors | 2002 | L. Giovannelli; A. Cozzi; I. Guarnieri; P. Dolara; F. Moroni | |
Endocannabinoids play a crucial role in the mechanisms of mGlu1-mediated neuroprotection in models of cerebral ischemia. | 2008 | Landucci E.; Scartabelli T.; Cozzi A.; Boscia F.; Mannaioni G.; Annunziato L.; Moroni F.; Pellegrini-Giampietro D.E. | |
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany | 2019 | Cristina Stasi; Caterina Silvestri; Roberto Berni; Maurizia Rossana Brunetto; Anna Linda Zignego; Cristina Orsini; Stefano Milani; Liana Ricciardi; Andrea De Luca; Pierluigi Blanc; Cesira Nencioni; Donatella Aquilini; Alessandro Bartoloni; Giampaolo Bresci; Santino Marchi; Franco Filipponi; Piero Colombatto; Paolo Forte; Andrea Galli; Sauro Luchi; Silvia Chigiotti; Alessandro Nerli; Giampaolo Corti; Rodolfo Sacco; Paola Carrai; Angelo Ricchiuti; Massimo Giusti; Paolo Almi; Andrea Cozzi; Silvia Carloppi; Giacomo Laffi; Fabio Voller; Francesco Cipriani | |
GAT-1 regulates both tonic and phasic GABAA receptor-mediated inhibition in the cerebral cortex | 2008 | L. BRAGINA; I. MARCHIONNI; A. OMRANI; A. COZZI; D.E. PELLEGRINI-GIAMPIETRO; E. CHERUBINI; F. CONTI | |
GLT-1 expression and glutamate uptake in rat cerebral cortex are increased by phencyclidine | 2008 | G.Fattorini; M.Melone; L.Bragina; C.Candiracci; A.Cozzi; D.E.Pellegrini-Giampietro; M.Torres-Ramos; A.Pérez-Samartín; C.Matute; F.Conti | |
GPR35 is functionally expressed in astrocytes and mediates kynurenic acid-dependent reduction of excitatory synaptic activity at CA3-CA1 synapse. | 2010 | Masi A; Cavone L; Sili M; Cozzi A; Berlinguer Palmini R; Cosi C; Moroni F; Mannaioni G | |
HCV Patients Psychopathology and Tryptophan Metabolism: Analysis of the Effects of Pegylated Interferon plus Ribavirin Treatment | 2007 | A.L. Zignego; A. Cozzi; R. Carpenedo; C. Giannini; M. Rosselli; T. Biagioli; A. Aldinucci; G. Laffi; F. Moroni | |
Interplay between group I mGlu receptors and the endocannabinoid system in the CA1 hippocampal area: studies in models of cerebral ischemia | 2008 | Landucci E.; Scartabelli T.; Moneti G.; Boscia F.; Cozzi A.; Moroni F.; Mannaioni G.; Pellegrini-Giampietro D.E. | |
Involvement of endocannabinoid signaling in the neuroprotective effects of subtype 1 metabotropic glutamate receptor antagonists in models of cerebral ischemia | 2009 | E.Landucci; F.Boscia; E.Gerace; T.Scartabelli; A.Cozzi; F.Moroni; G.Mannaioni; D.E.Pellegrini-Giampietro | |
Kynurenic acid actions in brain and periphey | 2007 | F. Moroni; S. Fossati; A. Chiarugi; A. Cozzi | |
Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro. | 2005 | C. DI SERIO; A. COZZI; I. ANGELI; L. DORIA; I. MICUCCI; S. PELLERITO; P. MIRONE; G. MASOTTI; F. MORONI; F. TARANTINI | |
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. | 2012 | F. Moroni;A. Cozzi;M. Sili;G. Mannaioni | |
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. | 2001 | CHIARUGI A; COZZI A; BALLERINI C; MASSACESI L; F. MORONI | |
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus | 2005 | F. MORONI; A. COZZI; R. CARPENEDO; G. CIPRIANI; O. VENERONI; E. IZZO |